Overview
- California Attorney General Rob Bonta announced the settlement with the U.S. Department of Justice.
- Officials alleged CVS used false electronic certifications and failed to verify required documentation for pharmacy claims from 2010 to 2021.
- The matter originated from a whistleblower complaint filed by a former CVS pharmacist under qui tam provisions.
- The investigation was led jointly by the California DOJ’s Division of Medi-Cal Fraud and Elder Abuse and the U.S. Attorney’s Office for the Eastern District of California.
- The United States will receive 44.34% of the proceeds, and CVS resolved the case without admitting liability.